UMC 0256 UMEDIC GROUP BERHAD | A Growing Company (Q3FY2023)
With the advancement of global medical technology and increased cross-border collaborations, the research, development, and manufacturing of high-end medical devices have been continuously improving. The application of new materials, sensors, artificial intelligence, and machine learning technologies has greatly facilitated the innovation and progress of high-end medical devices.
Just a few days ago, UMedic Group Berhad (UMC, 0256), a high-end medical equipment provider, released an impressive performance report, leading to a surge in the company's stock price.
Let's briefly comprehend this company’s background. Headquartered in Penang, UMC was established in 2002 and went public on the ACE Market in July 2022. The company is primarily engaged in the manufacturing, marketing, and after-sales services of various medical devices. It is worth mentioning that the company holds distribution rights for multiple international medical equipment companies, including GE Healthcare, Mindray, and Philips. In addition, UMC develops and manufactures its own brand of medical products, namely the HydroX series of prefilled humidifiers and the AirdroX series of asthma spacers.
To date, UMC has provided professional medical equipment and related services to thousands of customers, including public and private hospitals, healthcare service providers, hotels, airports, factories, and more, spanning over 30 countries worldwide. According to the 2022 annual report, UMC's customers are primarily from Malaysia, accounting for approximately 80.09% of the total revenue for the 2022 financial year. The Asia-Pacific region, including South Korea, India, Indonesia, Myanmar, the Philippines, Thailand, and Brunei, accounted for approximately 10.29% of the revenue. The remaining markets include Europe (6.84%), the United States (1.78%), the Middle East (0.47%), Oceania (0.35%), and Africa (0.18%).
Now, let's discuss UMC's latest performance in Q3FY2023.
Revenue Comparison (YoY +48.22%, QoQ -23.40%)
For the third quarter ending on April 30, 2023, the company achieved revenue of approximately RM9.59 million, an increase of approximately RM3.12 million or 48.22% compared to the same period last year, which was around RM6.47 million. This growth was primarily due to increased demand for medical devices from both public and private hospitals, as well as healthcare service providers. Additionally, the management stated that the revenue growth was also driven by increased sales of the company's HydroX and AirdroX products.
However, compared to the immediate preceding quarter, the company's revenue decreased by approximately RM2.93 million or 23.40%. This was due to a decline in sales of medical devices.
Net Profit Comparison (YoY +58.13%, QoQ -29.89%)
Benefiting from favorable foreign exchange rates and the growth in sales of medical devices and related products, the company's net profit increased by approximately RM0.75 million or 58.13% year-on-year, reaching around RM2.04 million.
As mentioned earlier, due to the decline in medical device sales this quarter, the company's net profit decreased by approximately RM0.87 million or 29.89% compared to the immediate preceding quarter.
Outlook
This year, the Malaysian Ministry of Health received a budget allocation of approximately RM36.30 billion through Budget 2023, which is higher than the previous year's allocation of around RM32.40 billion. This indicates that the government places significant emphasis on the domestic healthcare sector, which is good news for UMC. Therefore, the management remains confident about the company's future profit growth.
So, what are your thoughts on UMC, currently trading at a price-to-earnings ratio (P/E) of approximately 36.58?
#UMC
https://xifu.my/OpinionsComment.aspx?BID=B02284008PBAB0E0
Singapore Investment
-
-
-
-
-
-
Musk’s xAI launches API10 hours ago
-
-
-
-
Union Square Residences12 hours ago
-
-
-
AAC Teh (2018): Potential Mark Up20 hours ago
-
-
-
-
-
-
-
-
-
Best Areas in Seoul to Buy Property2 days ago
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The gold rush again1 week ago
-
Finance Investment Movement 501 week ago
-
-
-
-
-
-
-
-
-
I quit my Full time job!2 weeks ago
-
-
Sep 2024 Portfolio2 weeks ago
-
-
-
-
-
SGX share price on 3-year high!2 weeks ago
-
-
-
-
-
-
-
Summary of September 20242 weeks ago
-
-
-
-
-
-
3Q 2024 Investment Strategy Update3 weeks ago
-
A peek behind the curtain3 weeks ago
-
-
Portfolio (Sep 30, 2024)3 weeks ago
-
-
China boom?3 weeks ago
-
-
-
-
PSA Annoucement: Life of a minion3 weeks ago
-
STI ETF4 weeks ago
-
-
-
-
-
-
-
-
-
-
Unibet Casino Bonus Codes 20241 month ago
-
-
-
-
-
MSC: Mission Critical distributor1 month ago
-
500k Milestone!2 months ago
-
Random thoughts: Air Drying of car2 months ago
-
-
-
-
-
-
-
-
-
-
-
Monthly IBKR Update – June 20243 months ago
-
At the Half Year Mark3 months ago
-
-
-
-
-
-
-
-
-
Breakthroughs in portfolio :)4 months ago
-
-
-
-
-
Feb 2024 Expenditure6 months ago
-
-
The Market Is A Scam!7 months ago
-
-
-
Options Trading Journal Jan 20248 months ago
-
-
-
-
Year 2023 DIYQuant Portfolio Performance Report9 months ago
-
Monthly Summary of November 202310 months ago
-
Migration of website10 months ago
-
-
-
-
-
-
-
-
-
-
A New Light1 year ago
-
-
-
-
-
-
2022 Thoughts, Hello 2023!1 year ago
-
Series of Defaults for Maple Finance1 year ago
-
Takeaways from “Sea Change”1 year ago
-
Greed is Coming Back1 year ago
-
-
-
-
-
-
-
-
-
-
-
What is Overemployment2 years ago
-
Terra Hill Condo (former Flynn Park)2 years ago
-
Alibaba VS Tencent: The Battle Royale2 years ago
-
-
-
-
-
-
-
-
-